New ANDA Cases

Summer 2014

GENERICally Speaking
Case Name Date Filed Judge Drug Patent No(s).

Torrent Pharms. Ltd. v. Merck Frosst Canada & Co., IPR2014-00559 (PTAB)

Apr. 1, 2014

N/A

Daliresp® (roflumilast tablets)

6,448,274

Bayer Pharma AG v. Par Pharm., Inc., 14-2065 (D.N.J.)

Apr. 2, 2014

Hon. Jose L. Linares

Staxyn® (vardenafil hydrochloride tablets)

8,613,950

Noven Pharms., Inc. v. Novartis AG, IPR2014-00549 (PTAB)

Apr. 2, 2014

N/A

Exelon® (rivastigmine extended-release film)

6,316,023

Noven Pharms., Inc. v. Novartis AG, IPR2014-00550 (PTAB)

Apr. 2, 2014

N/A

Exelon® (rivastigmine extended-release film)

6,335,031

Purdue Pharma L.P. v. Teva Pharms. USA, Inc., 14-2357 (S.D.N.Y.)

Apr. 3, 2014

Hon. Sidney H. Stein

OxyContin® (oxycodone hydrochloride extended-release tablets)

6,488,963

Otsuka Pharm. Co., Ltd. v. Hetero USA Inc., 14-0421 (D. Del.)

Apr. 4, 2014

Hon. Richard G. Andrews

Samsca® (tolvaptan tablets)

8,501,730

Reckitt Benckiser Pharms. Inc. v. Par Pharm., Inc., 14-0422 (D. Del.)

Apr. 4, 2014

Hon. Richard G. Andrews

Suboxone® (buprenorphine hydrochloride / naloxone hydrochloride sublingual film)

8,475,832
8,017,150
8,603,514

Sanofi v. Alembic Pharms. Ltd., 14-0424 (D. Del.)

Apr. 4, 2014

Hon. Richard G. Andrews

Multaq® (dronedarone tablets)

7,323,493
8,318,800
8,410,167
8,602,215

Helsinn Healthcare S.A. v. Cipla Ltd., 14-0427 (D. Del.)

Apr. 7, 2014

Hon. Gregory M. Sleet

Aloxi® (palonosetron hydrochloride intravenous solution)

8,598,218
8,598,219

Mallinckrodt LLC v. Metrics, Inc., 14-2219 (D.N.J.)

Apr. 7, 2014

Hon. Susan D. Wigenton

Pennsaid® (diclofenac sodium topical solution)

8,217,078
8,546,450
8,618,164

Kowa Co., Ltd. v. Aurobindo Pharma Ltd., 14-2497 (S.D.N.Y.)

Apr. 9, 2014

Hon. Paul A. Crotty

Livalo® (pitavastatin calcium tablets)

5,856,336
8,557,993

Kowa Co., Ltd. v. Aurobindo Pharma Ltd., 14-2290 (D.N.J.)

Apr. 10, 2014

Hon. Peter G. Sheridan

Livalo® (pitavastatin calcium tablets)

5,856,336
8,557,993

Novartis Pharms. Corp. v. Dr. Reddy's Labs., Ltd., 14-2329 (D.N.J.)

Apr. 10, 2014

Hon. Claire C. Cecchi

Gleevec® (imatinib mesylate capsules)

RE43,932

The Medicines Co. v. Aurobindo Pharma Ltd., 14-2367 (D.N.J.)

Apr. 11, 2014

Hon. Peter G. Sheridan

Angiomax® (bivalirudin for injection)

7,582,727
7,598,343

Glenmark Generics Ltd. v. Sanofi-Aventis U.S. LLC, 14-2374 (D.N.J.)

Apr. 11, 2014

Hon. Stanley R. Chesler

DDAVP® (desmopressin acetate tablets)

7,022,340

Kowa Co., Ltd. v. Mylan, Inc., 14-2647 (S.D.N.Y.)

Apr. 14, 2014

Hon. Paul A. Crotty

Livalo® (pitavastatin calcium tablets)

5,856,336
6,465,477
8,557,993

Eli Lilly and Co. v. Apotex Corp., 14-0586 (S.D. Ind.)

Apr. 16, 2014

Hon. Sarah Evans Barker

Effient® (prasugrel hydrochloride tablets)

8,404,703
8,569,325

Endo Pharms., Inc. v. Depomed, Inc., IPR2014-00651, -00652 (PTAB)

Apr. 17, 2014

N/A

Gralise® (gabapentin tablets)

6,723,340

Endo Pharms., Inc. v. Depomed, Inc., IPR2014-00653, -00654 (PTAB)

Apr. 17, 2014

N/A

Gralise® (gabapentin tablets)

6,340,475

Endo Pharms., Inc. v. Depomed, Inc., IPR2014-00655, -00656 (PTAB)

Apr. 17, 2014

N/A

Gralise® (gabapentin tablets)

6,635,280

Kowa Co., Ltd. v. Mylan, Inc., 14-0504 (W.D. Pa.)

Apr. 17, 2014

Hon. Arthur J. Schwab

Livalo® (pitavastatin calcium tablets)

5,856,336
6,465,477
8,557,993

Kowa Co., Ltd. v. Amneal Pharms., LLC, 14-2758 (S.D.N.Y.)

Apr. 17, 2014

Hon. Paul A. Crotty

Livalo® (pitavastatin calcium tablets)

5,856,336
8,557,993

Kowa Co., Ltd. v. Orient Pharma Co., Ltd., 14-2759 (S.D.N.Y.)

Apr. 17, 2014

Hon. Paul A. Crotty

Livalo® (pitavastatin calcium tablets)

5,856,336
6,465,477
8,557,993

Kowa Co., Ltd. v. Zydus Pharms. (USA) Inc., 14-2760 (S.D.N.Y.)

Apr. 17, 2014

Hon. Paul A. Crotty

Livalo® (pitavastatin calcium tablets)

5,856,336
6,465,477
8,557,993

Hospira, Inc. v. Aurobindo Pharma Ltd., 14-0486 (D. Del.)

Apr 18, 2014

Hon. Gregory M. Sleet

Precedex® (dexmedetomidine hydrochloride injection)

6,716,867

Hospira, Inc. v. Ben Venue Labs., Inc., 14-0487 (D. Del.)

Apr 18, 2014

Hon. Gregory M. Sleet

Precedex® (dexmedetomidine hydrochloride injection)

6,716,867

Hospira, Inc. v. Actavis US Holding LLC, 14-0488 (D. Del.)

Apr 18, 2014

Hon. Gregory M. Sleet

Precedex® (dexmedetomidine hydrochloride injection)

6,716,867

Hospira, Inc. v. Akorn, Inc., 14-2811 (N.D. Ill.)

Apr 18, 2014

Hon. Robert M. Dow, Jr.

Precedex® (dexmedetomidine hydrochloride injection)

6,716,867

Hospira, Inc. v. Intas Pharms. Ltd., 14-0336 (M.D.N.C.)

Apr 18, 2014

Hon. N. C. Tilley, Jr.

Precedex® (dexmedetomidine hydrochloride injection)

6,716,867

Kowa Co., Ltd. v. Amneal Pharms., LLC, 14-2488 (D.N.J.)

Apr. 18, 2014

Hon. Peter G. Sheridan

Livalo® (pitavastatin calcium tablets)

5,856,336
8,557,993

Forest Labs., Inc. v. Amneal Pharms. LLC, 14-0508 (D. Del.)

Apr. 21, 2014

Hon. Leonard P. Stark

Namenda XR® (memantine hydrochloride extended-release capsules)

5,061,703
8,039,009
8,168,209
8,173,708
8,283,379
8,329,752
8,362,085
8,598,233

Amarin Pharma, Inc. v. Apotex, Inc., 14-2550 (D.N.J.)

Apr. 21, 2014

Hon. Mary L. Cooper

Vascepa® (icosapent ethyl capsules)

8,293,728
8,318,715
8,357,677
8,367,652
8,377,920
8,399,446
8,415,335
8,426,399
8,431,560
8,440,650
8,501,225
8,518,929
8,524,698
8,546,372
8,551,521
8,617,594

Amarin Pharma, Inc. v. Roxane Labs., Inc., 14-2551 (D.N.J.)

Apr. 21, 2014

Hon. Mary L. Cooper

Vascepa® (icosapent ethyl capsules)

8,293,728
8,318,715
8,357,677
8,367,652
8,377,920
8,399,446
8,415,335
8,426,399
8,431,560
8,440,650
8,501,225
8,518,929
8,524,698
8,546,372
8,551,521
8,617,594

Kowa Co., Ltd. v. Zydus Pharms. (USA) Inc., 14-2552 (D.N.J.)

Apr. 22, 2014

Hon. Peter J. Sheridan

Livalo® (pitavastatin calcium tablets)

5,856,336
6,465,477
8,557,993

Hyperion Therapeutics, Inc. v. Par Pharm., Inc., 14-0384 (E.D. Tex.)

Apr. 23, 2014

Hon. Rodney Gilstrap

Ravicti® (glycerol phenylbutyrate oral liquid)

8,404,215
8,642,012

AbbVie, Inc. v. Hetero USA Inc., 14-0543 (D. Del.)

Apr. 24, 2014

Hon. Richard G. Andrews

Norvir® (ritonavir tablets)

8,470,347
8,399,015

Amarin Pharma, Inc. v. Apotex, Inc. 14-2958 (N.D. Ill.)

Apr. 24, 2014

Hon. James F. Holderman

Vascepa® (icosapent ethyl capsules)

8,293,728
8,318,715
8,357,677
8,367,652
8,377,920
8,399,446
8,415,335
8,426,399
8,431,560
8,440,650
8,501,225
8,518,929
8,524,698
8,546,372
8,551,521
8,617,594

Dow Pharm. Sciences, Inc. v. Actavis, Inc., 14-2661 (D.N.J.)

Apr. 25, 2014

Hon. Stanley R. Chesler

Acanya® (clindamycin phosphate / benzoyl peroxide gel)

8,663,699

The Medicines Co. v. Exela Pharma Sciences, LLC, 14-0058 (W.D.N.C.)

Apr. 25, 2014

Hon. Richard Voorhees

Angiomax® (bivalirudin for injection)

7,582,727
7,598,343

Amarin Pharma, Inc. v. Roxane Labs., Inc., 14-0901 (N.D. Ohio)

Apr. 25, 2014

Hon. Christopher A. Boyko

Vascepa® (icosapent ethyl capsules)

8,293,728
8,318,715
8,357,677
8,367,652
8,377,920
8,399,446
8,415,335
8,426,399
8,431,560
8,440,650
8,501,225
8,518,929
8,524,698
8,546,372
8,551,521
8,617,594

Otsuka Pharm. Co., Ltd. v. Amneal Pharms., LLC, 14-2700 (D.N.J.)

Apr. 28, 2014

Hon. Mary L. Cooper

Abilify® (aripiprazole oral solution)

8,642,600

Cephalon, Inc. v. Uman Pharma Inc., 14-0568 (D. Del.)

Apr. 30, 2014

Hon. Gregory M. Sleet

Treanda® (bendamustine hydrochloride powder per vial for infusion)

8,445,524
8,436,190

Celgene Corp. v. Fresenius Kabi USA, LLC, 14-0571 (D. Del.)

Apr. 30, 2014

Hon. Richard G. Andrews

Istodax® (romidepsin for injection)

7,608,280
7,611,724

Amarin Pharma, Inc. v. Dr. Reddy's Labs., Inc., 14-2760 (D.N.J.)

Apr. 30, 2014

Hon. Mary L. Cooper

Vascepa® (icosapent ethyl capsules)

8,293,728
8,318,715
8,357,677
8,367,652
8,377,920
8,399,446
8,415,335
8,426,399
8,431,560
8,440,650
8,501,225
8,518,929
8,524,698
8,546,372
8,551,521
8,617,594

Cephalon, Inc. v. Uman Pharma Inc., 14-3114 (S.D.N.Y.)

May 1, 2014

Hon. Thomas P. Griesa

Treanda® (bendamustine hydrochloride powder per vial for infusion)

8,445,524
8,436,190

Senju Pharm. Co., Ltd. v. Aurobindo Pharma Ltd., 14-0579 (D. Del.)

May 2, 2014

Hon. Sue L. Robinson

Zymaxid® (gatifloxacin) ophthalmic solution)

6,333,045

Impax Labs., Inc. v. Meda Pharms., Inc., IPR2014-00731 (PTAB)

May 7, 2014

N/A

Astepro® (azelastine hydrochloride nasal spray)

8,071,073

Kowa Co., Ltd. v. Orient Pharma Co., Ltd., 14-3336 (N.D. Ill.)

May 7, 2014

Hon. Matthew F. Kennelly

Livalo® (pitavastatin calcium tablets)

5,856,336
6,465,477
8,557,993

Cephalon, Inc. v. Innopharma, Inc., 14-0590 (D. Del.)

May 9, 2014

Hon. Gregory M. Sleet

Treanda® (bendamustine hydrochloride powder for IV)

8,609,863

Otsuka Pharm. Co., Ltd. v. Almebic Pharms. Ltd., 14-2982 (D.N.J.)

May 9, 2014

Hon. Jerome B. Simandle

Abilify® (aripiprazole tablets)

8,017,615
8,580,796
8,642,760
8,518,421

Alza Corp. v. Mylan Pharms. Inc., 14-0594 (D. Del.)

May 12, 2014

Hon. Richard G. Andrews

Concerta® (methylphenidate hydrochloride)

8,163,798

Alza Corp. v. Mylan Pharms. Inc., 14-0085 (N.D.W.V.)

May 15, 2014

Hon. Irene M. Keeley

Concerta® (methylphenidate hydrochloride)

8,163,798

Celgene Corp. v. Natco Pharma Ltd., 14-3126 (D.N.J.)

May 15, 2014

Hon. Susan D. Wigenton

Revlimid® (lenalidomide capsules)

8,530,498
8,589,188
8,626,531
8,648,095

Otsuka Pharm. Co., Ltd. v. Zydus Pharms. USA Inc., 14-3168 (D.N.J.)

May 16, 2014

Hon. Jerome B. Simandle

Abilify® (aripiprazole tablets)

8,017,615
8,580,796
8,642,760
8,518,421

Dr. Reddy's Labs., Inc. v. Purdue Pharm. Products L.P., 14-3230 (D.N.J.)

May 20, 2014

Hon. Jose L. Linares

Intermezzo® (zolpidem tartrate sublingual tablets)

7,658,945

Jazz Pharms., Inc. v. Amneal Pharms., LLC, 14-3235 (D.N.J.)

May 20, 2014

Hon. Esther Salas

Xyrem® (sodium oxybate oral solution)

8,589,182

Alcon Research, Ltd. v. Watson Labs., Inc., 14-0647 (D. Del.)

May 20, 2014

Hon. Sue L. Robinson

Travatan Z® (travoprost ophthalmic solution)

8,268,299
8,323,630
8,388,941

Amarin Pharma, Inc. v. Watson Labs., Inc., 14-3259 (D.N.J.)

May 21, 2014

Hon. Mary L. Cooper

Vascepa® (icosapent ethyl capsules)

8,293,728
8,318,715
8,357,677
8,367,652
8,377,920
8,399,446
8,415,335
8,426,399
8,431,560
8,440,650
8,501,225
8,518,929
8,524,698
8,546,372
8,551,521
8,617,594

Allergan, Inc. v. Actavis PLC, 14-0638 (E.D. Tex.)

May 22, 2014

Hon. Rodney Gilstrap

Restasis® (cyclosporine ophthalmic emulsion 0.05%)

8,633,162
8,642,556
8,648,048
8,685,930

Otsuka Pharm. Co., Ltd. v. Aurobindo Pharma Ltd., 14-3306 (D.N.J.)

May 23, 2014

Hon. Jerome B. Simandle

Abilify® (aripiprazole tablets)

8,017,615
8,580,796
8,642,760

AstraZeneca AB v. Aurobindo Pharma Ltd., 14-0664 (D. Del.)

May 23, 2014

Hon. Gregory M. Sleet

Onglyza® (saxagliptin hydrochloride tablets)

7,951,400

AstraZeneca AB v. Glenmark Generics Ltd., 14-0665 (D. Del.)

May 23, 2014

Hon. Gregory M. Sleet

Onglyza® (saxagliptin hydrochloride tablets)

7,951,400

AstraZeneca AB v. Watson Labs., Inc., 14-0666 (D. Del.)

May 23, 2014

Hon. Gregory M. Sleet

Onglyza® (saxagliptin hydrochloride tablets)

7,951,400

AstraZeneca AB v. Wockhardt BIO AG, 14-0667 (D. Del.)

May 23, 2014

Hon. Gregory M. Sleet

Onglyza® (saxagliptin hydrochloride tablets)

RE44,186
7,951,400

AstraZeneca AB v. Watson Labs., Inc., 14-3428 (D.N.J.)

May 24, 2014

Hon. Mary L. Cooper

Onglyza® (saxagliptin hydrochloride tablets)

7,951,400

Cephalon, Inc. v. Breckenridge Pharm., Inc., 14-0671 (D. Del.)

May 27, 2014

Hon. Gregory M. Sleet

Treanda® (bendamustine hydrochloride powder for IV)

8,445,524
8,436,190
8,609,863

Torrent Pharms. Ltd. v. Novartis AG, IPR2014-00784 (PTAB)

May 27, 2014

N/A

Gilenya® (fingolimod capsules)

8,324,283

Pack Pharms. LLC v. Alza Corp., IPR2014-00868 (PTAB)

May 30, 2014

N/A

Glucotrol® XL (glipizide extended release tablets)

RE44,459

Forest Labs., Inc. v. Ranbaxy, Inc., 14-0686 (D. Del.)

May 30, 2014

Hon. Leonard P. Start

Namenda XR® (memantine hydrochloride extended-release capsules)

8,168,209
8,173,708
8,283,379
8,329,752
8,362,085
8,598,233

Otsuka Pharm. Co., Ltd. v. Wockhardt Bio AG, 14-3445 (D.N.J.)

May 30, 2014

Hon. Jerome B. Simandle

Abilify® (aripiprazole tablets)

8,642,760

Apotex Corp. v. ViiV Healthcare UK Ltd., IPR2014-00876 (PTAB)

June 2, 2014

N/A

Epzicom® (abacavir sulfate / lamivudine tablets) Trizivir® (abacavir sulfate / lamivudine / zidovudine tablets)

6,417,191

AstraZeneca AB v. Sun Pharma Global FZE, 14-0694 (D. Del.)

June 2, 2014

Hon. Gregory M. Sleet

Onglyza® (saxagliptin hydrochloride tablets) Kombiglyze XR™ (saxagliptin hydrochloride / metformin hydrochloride extended-release tablets)

RE44,186 7,951
400 8,628,799

AstraZeneca AB v. Teva Pharm. USA, Inc., 14-0695 (D. Del.)

June 2, 2014

Hon. Gregory M. Sleet

Onglyza® (saxagliptin hydrochloride tablets)

7,951,400

AstraZeneca AB v. Mylan Pharms., Inc., 14-0696 (D. Del.)

June 2, 2014

Hon. Gregory M. Sleet

Onglyza® (saxagliptin hydrochloride tablets) Kombiglyze XR™ (saxagliptin hydrochloride / metformin hydrochloride extended-release tablets)

RE44,186
7,951,400
8,628,799

AstraZeneca AB v. Amneal Pharms. LLC, 14-0697 (D. Del.)

June 2, 2014

Hon. Gregory M. Sleet

Onglyza® (saxagliptin hydrochloride tablets) Kombiglyze XR™ (saxagliptin hydrochloride / metformin hydrochloride extended-release tablets)

RE44,186
7,951,400
8,628,799

AstraZeneca AB v. Apotex Corp., 14-0698 (D. Del.)

June 2, 2014

Hon. Gregory M. Sleet

Onglyza® (saxagliptin hydrochloride tablets)

7,951,400

Gilead Sciences, Inc. v. Mylan Inc., 14-3928 (S.D.N.Y.)

June 2, 2014

Hon. Richard J. Sullivan

Truvada® (emtricitabine / tenofovir disoproxil fumarate tablets)

6,642,245
6,703,396
8,592,397

AstraZeneca Pharms. LP v. Sandoz Inc., 14-3547 (D.N.J.)

June 3, 2014

Hon. Renee Marie Bumb

Faslodex® (fulvestrant injection)

6,774,122
7,456,160
8,329,680
8,466,139

AstraZeneca AB v. Sun Pharma Global FZE, 14-3552 (D.N.J.)

June 3, 2014

Hon. Mary L. Cooper

Onglyza® (saxagliptin hydrochloride tablets) Kombiglyze XR™ (saxagliptin hydrochloride / metformin hydrochloride extended-release tablets)

RE44,186
7,951,400
8,628,799

AstraZeneca AB v. Mylan Pharms., Inc., 14-0094 (N.D.W.V.)

June 3, 2014

Hon. Irene M. Keeley

Onglyza® (saxagliptin hydrochloride tablets) Kombiglyze XR™ (saxagliptin hydrochloride / metformin hydrochloride extended-release tablets)

RE44,186
7,951,400
8,628,799

Mylan Pharms. Inc. v. Gilead Sciences, Inc., IPR2014-00885 (PTAB)

June 4, 2014

N/A

Stribild® (cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil fumarate tablets)
Atripla® (efavirenz / emtricitabine / tenofovir disoproxil fumarate tablets)
Complera® (emtricitabine / rilpivirine hydrochloride / tenofovir disoproxil fumarate tablets)
Truvada® (emtricitabine / tenofovir disoproxil fumarate tablets)
Viread® (tenofovir disoproxil fumarate tablets)

5,922,695

Mylan Pharms. Inc. v. Gilead Sciences, Inc., IPR2014-00886 (PTAB)

June 4, 2014

N/A

Stribild® (cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil fumarate tablets)
Atripla® (efavirenz / emtricitabine / tenofovir disoproxil fumarate tablets)
Complera® (emtricitabine / rilpivirine hydrochloride / tenofovir disoproxil fumarate tablets)
Truvada® (emtricitabine / tenofovir disoproxil fumarate tablets)
Viread® (tenofovir disoproxil fumarate tablets)

5,935,946

Mylan Pharms. Inc. v. Gilead Sciences, Inc., IPR2014-00887 (PTAB)

June 4, 2014

N/A

Stribild® (cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil fumarate tablets)
Atripla® (efavirenz / emtricitabine / tenofovir disoproxil fumarate tablets)
Complera® (emtricitabine / rilpivirine hydrochloride / tenofovir disoproxil fumarate tablets)
Truvada® (emtricitabine / tenofovir disoproxil fumarate tablets)
Viread® (tenofovir disoproxil fumarate tablets)

5,977,089

Mylan Pharms. Inc. v. Gilead Sciences, Inc., IPR2014-00888 (PTAB)

June 4, 2014

N/A

Stribild® (cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil fumarate tablets)
Atripla® (efavirenz / emtricitabine / tenofovir disoproxil fumarate tablets)
Complera® (emtricitabine / rilpivirine hydrochloride / tenofovir disoproxil fumarate tablets)
Truvada® (emtricitabine / tenofovir disoproxil fumarate tablets)
Viread® (tenofovir disoproxil fumarate tablets)

6,043,230

Helsinn Healthcare S.A. v. Mylan, Inc., 14-0709 (D. Del.)

June 4, 2014

Hon. Gregory M. Sleet

Aloxi® (palonosetron hydrochloride intravenous solution)

7,947,724
7,947,725
7,960,424
8,598,219
8,729,094

Amarin Pharma, Inc. v. Teva Pharms. USA, Inc., 14-3558 (D.N.J.)

June 4, 2014

Hon. Mary L. Cooper

Vascepa® (icosapent ethyl capsules)

8,293,728
8,318,715
8,357,677
8,367,652
8,377,920
8,399,446
8,415,335
8,426,399
8,431,560
8,440,650
8,501,225
8,518,929
8,524,698
8,546,372
8,551,521
8,617,594

Bristol-Myers Squibb Co. v. Aurobindo Pharma U.S.A., Inc., 14-3585 (D.N.J.)

June 4, 2014

Hon. Mary L. Cooper

Reyataz® (atazanavir sulfate capsules)

6,087,383

AstraZeneca AB v. Apotex Corp., 14-61309 (S.D. Fla.)

June 4, 2014

Hon. William P. Dimitrouleas

Onglyza® (saxagliptin hydrochloride tablets)

7,951,400

Teva Women's Health v. Lupin Ltd., 14-4055 (S.D.N.Y.)

June 4, 2014

Hon. Lorna G. Schofield

Quartette® (levonorgestrel / ethinyl estradiol tablets)

8,415,332
8,450,299

Warner Chilcott Co., LLC v. Amneal Pharms. LLC, 14-0718 (D. Del.)

June 6, 2014

Hon. Gregory M. Sleet

Enablex® (darifenacin hydrobromide extended-release tablets)

6,106,864

Warner Chilcott Co., LLC v. Lupin Atlantis Holdings S.A., 14-1827 (D. Md.)

June 6, 2014

Hon. Roger W. Titus

Minastrin® 24 Fe (ethinyl estradiol / norethindrone acetate tablets)

6,667,050

Cipher Pharms. Inc. v. Actavis Labs. FL, Inc., 14-3653 (D.N.J.)

June 6, 2014

Hon. Joseph E. Irenas

Absorica® (isotretinoin capsules)

7,435,427

Amarin Pharma, Inc. v. Teva Pharms. USA, Inc., 14-3251 (E.D. Pa.)

June 6, 2014

Hon. Nitza I. Quinones Alejandro

Vascepa® (icosapent ethyl capsules)

8,293,728
8,318,715
8,357,677
8,367,652
8,377,920
8,399,446
8,415,335
8,426,399
8,431,560
8,440,650
8,501,225
8,518,929
8,524,698
8,546,372
8,551,521
8,617,594

Gilead Sciences, Inc. v. Mylan Inc., 14-0099 (N.D.W.V.)

June 9, 2014

Hon. Irene M. Keeley

Truvada® (emtricitabine / tenofovir disoproxil fumarate tablets)

6,642,245
6,703,396
8,592,397

Vivus, Inc. v. Actavis Labs. FL, Inc., 14-3786 (D.N.J.)

June 12, 2014

Hon. Faith S. Hochberg

Qsymia® (phentermine / topiramate extended-release capsules)

7,056,890
7,553,818
7,659,256
7,674,776
8,580,298
8,580,299

Alza Corp. v. Sandoz Inc., 14-0744 (D. Del.)

June 13, 2014

Hon. Richard G. Andrews

Concerta® (methylphenidate hydrochloride extended-release tablets)

8,163,798
8,629,179

Vanda Pharms. Inc. v. Roxane Labs., Inc., 14-0757 (D. Del.)

June 16, 2014

Hon. Gregory M. Sleet

Fanapt® (iloperidone tablets)

8,586,610

Alza Corp. v. Sandoz Inc., 14-3838 (D.N.J.)

June 13, 2014

Hon. Joseph E. Irenas

Concerta® (methylphenidate hydrochloride extended-release tablets)

8,163,798
8,629,179

Novartis AG v. Glenmark Pharms., Ltd., 14-0771 (D. Del.)

June 18, 2014

Hon. Leonard P. Stark

Myfortic® (mycophenolate sodium delayed-release tablets)

6,025,391
6,172,107
6,306,900

Merck Sharp & Dohme Corp. v. Fresenius Kabi USA, LLC, 14-3917 (D.N.J.)

June 18, 2014

Hon. Peter G. Sheridan

Emend® (fosaprepitant dimeglumine for injection)

5,691,336

Amarin Pharma, Inc. v. Andrx Labs., LLC, 14-3924 (D.N.J.)

June 18, 2014

Hon. Mary L. Cooper

Vascepa® (icosapent ethyl capsules)

8,293,728
8,318,715
8,357,677
8,367,652
8,377,920
8,399,446
8,415,335
8,426,399
8,431,560
8,440,650
8,501,225
8,518,929
8,524,698
8,546,372
8,551,521
8,617,594

Spectrum Pharms., Inc. v. Ben Venue Labs., Inc., 14-0980 (D. Nev.)

June 18, 2014

Hon. Gloria M. Navarro

Fusilev® (levoleucovorin calcium for injection)

6,500,829

Cephalon, Inc. v. Actavis Labs. FL, Inc., 14-0776 (D. Del.)

June 19, 2014

Hon. Sue L. Robinson

Fentora® (fentanyl buccal tablets)

6,200,604
6,264,981
8,119,158

Novartis Pharms. Corp. v. Mylan Inc., 14-0777 (D. Del.)

June 19, 2014

Hon. Richard G. Andrews

Exelon® (rivastigmine transdermal system or extended-release film)

6,316,023
6,335,031

Allos Therapeutics, Inc. v. Teva Pharms. USA, Inc., 14-0778 (D. Del.)

June 19, 2014

Hon. Richard G. Andrews

Folotyn® (pralatrexate for injection)

6,028,071
7,622,470
8,299,078

Pfizer Inc. v. CFT Pharms. LLC, 14-0781 (D. Del.)

June 19, 2014

Hon. Sue L. Robinson

Tygacil® (tigecycline injectable IV infusion)

7,879,828
8,372,995

Cephalon, Inc. v. Actavis Labs. FL, Inc., 14-3936 (D.N.J.)

June 19, 2014

Hon. Stanley R. Chesler

Fentora® (fentanyl buccal tablets)

6,200,604
6,264,981
8,119,158

Janssen Pharms., Inc. v. Roxane Labs., Inc., 14-3941 (D.N.J.)

June 19, 2014

Hon. Claire C. Cecchi

Nucynta® (tapentadol hydrochloride extended-release tablets)

RE39,593
7,994,364
8,536,130

Teva Women's Health, Inc. v. Watson Labs., Inc., 14-4439 (S.D.N.Y.)

June 19, 2014

Hon. John G. Koeltl

Quartette® (levonorgestrel / ethinyl estradiol tablets)

8,415,332
8,450,299

Otsuka Pharm. Co., Ltd. v. Par Pharm., Inc., 14-0789 (D. Del.)

June 20, 2014

Hon. Richard G. Andrews

Samsca® (tolvaptan tablets)

5,753,677
8,501,730

Avanir Pharms., Inc. v. Ranbaxy Labs. Ltd., 14-0792 (D. Del.)

June 20, 2014

Hon. Leonard P. Stark

Nuedexta® (dextromethorphan hydrobromide / quinidine sulfate capsules)

7,659,282
8,227,484

Senju Pharm. Co., Ltd. v. Metrics, Inc., 14-3962 (D.N.J.)

June 20, 2014

Hon. Jerome B. Simandle

Prolensa® (bromfenac ophthalmic solution)

8,129,431
8,669,290
8,754,131

Otsuka Pharm. Co., Ltd. v. Intas Pharms. Ltd., 14-3996 (D.N.J.)

June 20, 2014

Hon. Jerome B. Simandle

Abilify® (aripiprazole tablets)

8,017,615
8,580,796
8,642,760

Pfizer Inc. v. CFT Pharms. LLC, 14-0714 (E.D. Wis.)

June 20, 2014

Hon. William E. Duffin

Tygacil® (tigecycline injectable IV infusion)

7,879,828
8,372,995

Novartis Pharms. Corp. v. Mylan Inc., 14-0106 (N.D.W.V.)

June 20, 2014

Hon. Irene M. Keeley

Exelon® (rivastigmine transdermal system or extended-release film)

6,316,023
6,335,031

Biodelivery Sciences Int'l, Inc. v. RB Pharms. Ltd., IPR2014-00998 (PTAB)

June 20, 2014

N/A

Suboxone® (buprenorphine hydrochloride / naloxone hydrochloride sublingual film)

8,475,832

Amneal Pharms., LLC v. Jazz Pharms., Inc., CBM2014-00149 (PTAB)

June 24, 2014

N/A

Xyrem® (sodium oxybate oral solution)

7,895,059

Novartis Pharms. Corp. v. Mylan Inc., 14-0820 (D. Del.)

June 25, 2014

Hon. Richard G. Andrews

Exjade® (deferasirox tablets for oral suspension)

6,465,504
6,596,750

Shire LLC v. Ranbaxy Labs. Ltd., 14-0827 (D. Del.)

June 25, 2014

Hon. Richard G. Andrews

Intuniv® (guanfacine hydrochloride extended-release tablets)

6,287,599
6,811,794

Orexo AB v. Actavis Elizabeth LLC, 14-0829 (D. Del.)

June 26, 2014

Hon. Sue L. Robinson

Zubsolv® (buprenorphine hydrochloride / naloxone hydrochloride dihydrate sublingual tablets)

8,454,996
8,470,361
8,658,198

Eli Lilly and Co. v. Panacea Biotec, Ltd., 14-1064 (S.D. Ind.)

June 26, 2014

Hon. Sarah Evans Barker

Effient® (prasugrel hydrochloride tablets)

8,404,703
8,569,325

Senju Pharm. Co., Ltd. v. Lupin, Ltd., 14-4149 (D.N.J.)

June 26, 2014

Hon. Jerome B. Simandle

Prolensa® (bromfenac ophthalmic solution)

8,669,290

Novartis Pharms. Corp. v. Mylan Inc., 14-0111 (N.D.W.V.)

June 26, 2014

Hon. Irene M. Keeley

Exjade® (deferasirox tablets for oral suspension)

6,465,504
6,596,750

Metrics, Inc. v. Senju Pharm. Co., Ltd., IPR2014-01041 (PTAB)

June 26, 2014

N/A

Prolensa® (bromfenac ophthalmic solution)

8,129,431

Metrics, Inc. v. Senju Pharm. Co., Ltd., IPR2014-01043 (PTAB)

June 26, 2014

N/A

Prolensa® (bromfenac ophthalmic solution)

8,669,290

Forest Labs., Inc. v. Aurobindo Pharma USA Inc., 14-0833 (D. Del.)

June 27, 2014

Hon. Leonard P. Stark

Namenda® (memantine hydrochloride tablets)

5,061,703

UCB, Inc. v. Apotex Corp., 14-0834 (D. Del.)

June 27, 2014

Hon. Leonard P. Stark

Vimpat® (lacosamide oral solution)

RE38,551

Par Pharm., Inc. v. Novartis Pharms. Corp., 14-0843 (D. Del.)

June 27, 2014

Hon. Richard G. Andrews

Exelon® (rivastigmine transdermal system or extended-release film)

6,316,023

AstraZeneca AB v. Par Pharm., Inc., 14-0845 (D. Del.)

June 30, 2014

Hon. Gregory M. Sleet

Onglyza® (saxagliptin hydrochloride tablets)

7,951,400


Back to Top